Enterococcal bacteremia in children: Clinical Significance of vancomycin resistance

被引:0
|
作者
Jo, Kyo Jin [1 ]
Lee, Hyeon Seo [2 ]
Lee, Narae [1 ]
Byun, Shin Yun [1 ]
Chang, Chulhun [3 ]
Park, Su Eun [1 ]
机构
[1] Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Pediat, Yangsan, South Korea
[2] Pusan Natl Univ, Off Infect Control, Yangsan Hosp, Yangsan, South Korea
[3] Pusan Natl Univ, Sch Med, Dept Lab Med, Yangsan, South Korea
来源
PEDIATRICS AND NEONATOLOGY | 2025年 / 66卷 / 02期
关键词
Bacteremia; Children; Enterococcus; Vancomycin-resistant enterococci; BLOOD-STREAM INFECTIONS; RISK-FACTORS; EPIDEMIOLOGY;
D O I
10.1016/j.pedneo.2024.01.007
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: We aimed to describe the clinical and microbiological characteristics of enterococcal bacteremia, as well as the effect of Enterococcus resistance against vancomycin on clinical outcomes in Korean children. Methods: We retrospectively reviewed the medical records of children diagnosed with enterococci isolated from blood cultures at Pusan National University Children's Hospital between December 2009 and November 2021. Results: In total, 64 patients were enrolled in the study. The median age was 0 years (range 0-15), and 43 (67.2%) patients were male. Enterococcus faecalis (50%) was the most commonly identified bacterial strain. Significant underlying diseases were present in 60 patients (93.8%), and the source of bacteremia was identified in 36 patients (56.3%). Among these, intravascular device was the most common identifiable source. Fifty-six (87.5%) patients had previously received broad-spectrum antibiotics and 54 (84.4%) patients were nosocomial in origin. Twenty-nine (45.3%) strains were resistant to ampicillin, and 16 (25%) strains were resistant to vancomycin. All patients with vancomycin-resistant enterococci (VRE) had underlying disease (P = 0.199), and focus of bacteremia was significantly more frequent in VRE patients (P = 0.014). Of all the patients, after appropriate antibiotic treatment, five (7.8%) patients had recurrent enterococcal bacteremia, and seven (10.9%) patients were diagnosed with bacteremia, defined as other pathogens from blood culture. The 30-day mortality rate was 7.8%. Conclusion: Enterococcal bacteremia in children is usually nosocomial and occurs in children with serious underlying diseases. Because the number of enrolled patients and mortality were small in our study, it is difficult to identify whether the factor that determines prognosis in patients with enterococcal bacteremia is VRE or an underlying disease. Further studies with a large number of patients in a specific group are needed.
引用
收藏
页码:142 / 146
页数:5
相关论文
共 50 条
  • [21] Vancomycin resistance, esp, and strain relatedness:: a 1-year study of enterococcal bacteremia
    Harrington, SM
    Ross, TL
    Gebo, KA
    Merz, WG
    JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (12) : 5895 - 5898
  • [22] Chloramphenicol resistance in vancomycin-resistant enterococcal bacteremia: Impact of priop fluoroquinolone use?
    Gould, CV
    Fishman, NO
    Nachamkin, I
    Lautenbach, E
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2004, 25 (02): : 138 - 145
  • [23] Pharmacokinetic/Pharmacodynamic Determinants of Vancomycin Efficacy in Enterococcal Bacteremia
    Bin Jumah, Muhammed Taufiq
    Vasoo, Shawn
    Menon, Sanjay R.
    De, Partha Pratim
    Neely, Michael
    Teng, Christine B.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2018, 62 (03)
  • [24] Nosocomial enterococcal bacteremia in children
    Bilikova, E
    Babela, R
    Krcmery, V
    PEDIATRICS, 2003, 111 (02) : 445 - 446
  • [25] Therapeutic options for vancomycin-resistant enterococcal bacteremia
    Barber, Katie E.
    King, S. Travis
    Stover, Kayla R.
    Pogue, Jason M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2015, 13 (03) : 363 - 377
  • [26] A neutropenic leukemic child with vancomycin resistant Enterococcal bacteremia
    Hatipoglu, N.
    Aydogan, G.
    Siraneci, R.
    Akici, F.
    Salcioglu, Z.
    Uysal, F.
    Sen, H. S.
    Hatipoglu, H.
    Ulucakli, O.
    ACTA PAEDIATRICA, 2008, 97 : 187 - 187
  • [27] Enterococcal bacteremia in the surgical intensive care unit - Does vancomycin resistance affect mortality? Discussion
    Davis, JM
    Mainous, MR
    Simms, HH
    McManus, AT
    Barie, PS
    ARCHIVES OF SURGERY, 1997, 132 (01) : 81 - 81
  • [28] INVITRO DETECTION OF ENTEROCOCCAL VANCOMYCIN RESISTANCE
    SAHM, DF
    OLSEN, L
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (09) : 1846 - 1848
  • [29] An analysis of treatment of patients with vancomycin-resistant enterococcal bacteremia
    Feldman, RJ
    Paul, SM
    Silber, JL
    Cody, RP
    Noveck, H
    Weinstein, MP
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 1996, 5 (07) : 440 - 445
  • [30] Vancomycin-resistant enterococcal bacteremia in neutropenic patients with cancer
    Marron, A
    Carratalà, J
    Ayats, J
    de Sevilla, AF
    Domínguez, MA
    Liñares, J
    Gudiol, F
    MEDICINA CLINICA, 1998, 111 (20): : 761 - 764